Imagion to Present Prostate Cancer Research Data at WMIC 2022
Imagion to present prostate cancer research data at World Molecular Imaging Congress MagSense® molecular imaging agent shows high specificity and selectivity……
Half-Year Results for the First Half of 2022 and Appendix 4D
Today, we released our Appendix 4D and Half-Year Financial Report for the half-year ending 30 June 2022 to the ASX. 1H2022 Highlights: MagSense® HER2 breast…
Quarterly Activity Report and Appendix 4C for 30 June 2022
Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 30 June 2022. The announcement highlights: MagSense® HER2 imaging…
Quarterly Activity Report and Appendix 4C for 31 Mar 2022
Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 31 March 2022. The announcement highlights: MagSense® HER2 breast…
MagSense® HER2 Breast Cancer First-in-human Study Progress Update
Imagion Biosystems Limited (ASX: IBX) is pleased to provide an update on the progress of its first-in-human study for the MagSense® HER2 breast cancer imaging…
Quarterly Activity Report and Appendix 4C for 31 December 2021
Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 31 December 2021. The announcement highlights a recap of the…
Application for quotation of +securities
The document "Application for quotation of +securities" was lodged with ASX on 6th January, 2022. Please click to review the full announcement at ASX.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
The document "Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001" was lodged with ASX on 6th January, 2022. Please click to review the full…
Notification of Issue, Conversion of Payment up of Unquoted Equity Securities
The document "Notification of Issue, Conversion of Payment up of Unquoted Equity +Securities" was lodged with ASX on 16 December, 2021. Please click to review…
Remuneration Update and Employee Equity Incentives
The document "Remuneration Update and Employee Equity Incentives" was lodged with ASX on 16 December 2021. Please click to review the full announcement at ASX.